Correlation Between Codex Acquisitions and Sartorius Stedim

Can any of the company-specific risk be diversified away by investing in both Codex Acquisitions and Sartorius Stedim at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Codex Acquisitions and Sartorius Stedim into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Codex Acquisitions PLC and Sartorius Stedim Biotech, you can compare the effects of market volatilities on Codex Acquisitions and Sartorius Stedim and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Codex Acquisitions with a short position of Sartorius Stedim. Check out your portfolio center. Please also check ongoing floating volatility patterns of Codex Acquisitions and Sartorius Stedim.

Diversification Opportunities for Codex Acquisitions and Sartorius Stedim

0.0

Correlation Coefficient

Codex Acquisitions  Sartorius Stedim

Pay attention - limited upside

The 3 months correlation between Codex and Sartorius is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Codex Acquisitions PLC and Sartorius Stedim Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sartorius Stedim Biotech and Codex Acquisitions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Codex Acquisitions PLC are associated (or correlated) with Sartorius Stedim. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sartorius Stedim Biotech has no effect on the direction of Codex Acquisitions i.e., Codex Acquisitions and Sartorius Stedim go up and down completely randomly.

Pair Corralation between Codex Acquisitions and Sartorius Stedim

If you would invest  18,245  in Sartorius Stedim Biotech on October 9, 2024 and sell it today you would earn a total of  863.00  from holding Sartorius Stedim Biotech or generate 4.73% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	97.5%
Values	Daily Returns

Codex Acquisitions PLC  vs.  Sartorius Stedim Biotech

Codex Acquisitions PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Codex Acquisitions PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Codex Acquisitions is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Sartorius Stedim Biotech

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Sartorius Stedim may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Codex Acquisitions and Sartorius Stedim

The main advantage of trading using opposite Codex Acquisitions and Sartorius Stedim positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Codex Acquisitions position performs unexpectedly, Sartorius Stedim can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sartorius Stedim will offset losses from the drop in Sartorius Stedim's long position.

The idea behind Codex Acquisitions PLC and Sartorius Stedim Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..